Literature DB >> 11433349

Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis.

C Heeschen1, J J Jang, M Weis, A Pathak, S Kaji, R S Hu, P S Tsao, F L Johnson, J P Cooke.   

Abstract

We provide anatomic and functional evidence that nicotine induces angiogenesis. We also show that nicotine accelerates the growth of tumor and atheroma in association with increased neovascularization. Nicotine increased endothelial-cell growth and tube formation in vitro, and accelerated fibrovascular growth in vivo. In a mouse model of hind-limb ischemia, nicotine increased capillary and collateral growth, and enhanced tissue perfusion. In mouse models of lung cancer and atherosclerosis, we found that nicotine enhanced lesion growth in association with an increase in lesion vascularity. These effects of nicotine were mediated through nicotinic acetylcholine receptors at nicotine concentrations that are pathophysiologically relevant. The endothelial production of nitric oxide, prostacyclin and vascular endothelial growth factor might have a role in these effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11433349     DOI: 10.1038/89961

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  223 in total

1.  Cholinergic activation of hematopoietic stem cells: role in tobacco-related disease?

Authors:  Edwin Chang; E Camilla Forsberg; Jenny Wu; Susan S Prohaska; Rich Allsopp; Irving L Weissman; John P Cooke
Journal:  Vasc Med       Date:  2010-10       Impact factor: 3.239

2.  Environmental tobacco smoke furthers progression of diabetic nephropathy.

Authors:  David M Obert; Ping Hua; Meagan E Pilkerton; Wenguang Feng; Edgar A Jaimes
Journal:  Am J Med Sci       Date:  2011-02       Impact factor: 2.378

3.  Significance of smoking status regarding outcomes after radical prostatectomy.

Authors:  Jong Jin Oh; Sung Kyu Hong; Chang Wook Jeong; Seok-Soo Byun; Sang Eun Lee
Journal:  Int Urol Nephrol       Date:  2011-04-24       Impact factor: 2.370

Review 4.  Targeting NADPH oxidases in vascular pharmacology.

Authors:  Agata Schramm; Paweł Matusik; Grzegorz Osmenda; Tomasz J Guzik
Journal:  Vascul Pharmacol       Date:  2012-03-03       Impact factor: 5.773

5.  A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors.

Authors:  Christopher Heeschen; Michael Weis; Alexandra Aicher; Stefanie Dimmeler; John P Cooke
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

6.  Estimating the health consequences of replacing cigarettes with nicotine inhalers.

Authors:  W Sumner
Journal:  Tob Control       Date:  2003-06       Impact factor: 7.552

Review 7.  Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer.

Authors:  John D Minna
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

8.  Abstinence from smoking reduces incisional wound infection: a randomized, controlled trial.

Authors:  George P Yang; Michael T Longaker
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

9.  Smoking and mortality in women diagnosed with breast cancer-a systematic review with meta-analysis based on 400,944 breast cancer cases.

Authors:  Martin Sollie; Camilla Bille
Journal:  Gland Surg       Date:  2017-08

Review 10.  Endothelial nicotinic acetylcholine receptors and angiogenesis.

Authors:  John P Cooke; Yohannes T Ghebremariam
Journal:  Trends Cardiovasc Med       Date:  2008-10       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.